Central Serous Chorioretinopathy Associated with Tadalafil.

Author: AlarfajMotazz, AlhoutanKhalid, AlsarhaniAbdulaziz, AlsubaieHamad

Paper Details 
Original Abstract of the Article :
We report a case of central serous chorioretinopathy (CSCR) associated with tadalafil, a phosphodiesterase 5 inhibitor medication. In this report, we describe a case of a 59-year-old male who presented with blurred vision in the right eye. On examination, he was noted to have serous macular, pigment...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808129/

データ提供:米国国立医学図書館(NLM)

Tadalafil and Central Serous Chorioretinopathy: A Potential Link

Central serous chorioretinopathy (CSCR), a condition that affects the central part of the retina, can lead to blurred vision. This study reports a case of CSCR associated with tadalafil, a medication used to treat erectile dysfunction. It's like discovering a hidden connection between two seemingly unrelated elements in the desert, suggesting a possible link between tadalafil and CSCR.

A Cautionary Tale

The patient's visual symptoms and subretinal fluid resolved after discontinuing tadalafil. This is like realizing that a certain type of plant is causing an allergic reaction and removing it from the environment. This case highlights the importance of considering tadalafil as a potential cause of CSCR, particularly when patients present with visual symptoms. This is like being aware of potential hazards in the desert and taking precautions to avoid them.

Navigating the Desert of Ophthalmological Complications

Prescribing physicians should be aware of this potential side effect of tadalafil. This is like having a map of the desert, guiding us towards safe and effective treatment strategies. The addition of CSCR to the list of tadalafil's side effects can help healthcare professionals make informed decisions about the use of this medication. This is like adding new landmarks to our desert map, expanding our knowledge and understanding of the terrain.

Dr.Camel's Conclusion

This case report raises an important issue about the potential link between tadalafil and CSCR. It's like uncovering a hidden path in the desert, reminding us of the importance of ongoing research and careful monitoring of potential drug-related complications. This study highlights the ongoing need for vigilance in ophthalmology, ensuring the safety and well-being of patients.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-01-11
Further Info :

Pubmed ID

36605047

DOI: Digital Object Identifier

PMC9808129

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.